NewAmsterdam Pharma Co N.V 20-F for FY2022
NewAmsterdam Pharma Co N.V. (NAMS)
20-F
2023-03-31
For: 2022-12-31
View Original
Added on
April 09, 2026
About this 20-F
NewAmsterdam Pharma Co N.V filed this 20-F on March 31, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 97.5M EUR
- Net loss
- 78.05K EUR
- compared with a net loss of 28.6K EUR a year earlier
- Diluted EPS
- -0.96 EUR
- compared with -1.19 EUR a year earlier